Ya Hua Selected Research

Intraventricular Injections

1/2021	Cerebrospinal Fluid from Aneurysmal Subarachnoid Hemorrhage Patients Leads to Hydrocephalus in Nude Mice.
2/2020	Effects of aging on hydrocephalus after intraventricular hemorrhage.
1/2020	Prx2 (Peroxiredoxin 2) as a Cause of Hydrocephalus After Intraventricular Hemorrhage.
1/2016	Effects of Aerobic Capacity on Thrombin-Induced Hydrocephalus and White Matter Injury.
1/2016	Intraventricular Injection of Noncellular Cerebrospinal Fluid from Subarachnoid Hemorrhage Patient into Rat Ventricles Leads to Ventricular Enlargement and Periventricular Injury.
10/2014	Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats.
3/2014	Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya Hua Research Topics

Disease

79	Cerebral Hemorrhage 10/2022 - 01/2002
70	Brain Injuries (Brain Injury) 10/2022 - 01/2002
49	Brain Edema (Cerebral Edema) 01/2021 - 02/2002
26	Hematoma 03/2022 - 01/2002
21	Hydrocephalus (Hydrocephaly) 05/2022 - 01/2011
16	Hemorrhage 05/2022 - 09/2005
13	Atrophy 02/2022 - 02/2006
12	Brain Ischemia (Cerebral Ischemia) 01/2019 - 04/2002
11	Edema (Dropsy) 10/2022 - 02/2002
11	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 11/2010
9	Stroke (Strokes) 01/2021 - 02/2004
9	Infarction (Infarctions) 02/2018 - 04/2002
8	Neuroinflammatory Diseases 04/2021 - 09/2015
8	Iron Overload 01/2019 - 12/2003
5	Ischemic Stroke 01/2021 - 02/2009
4	Inflammation (Inflammations) 05/2022 - 09/2015
4	Hemorrhagic Stroke 01/2022 - 10/2016
4	Hypoxia (Hypoxemia) 01/2016 - 06/2002
4	Glioma (Gliomas) 01/2016 - 01/2008
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2012 - 04/2005
3	Thrombosis (Thrombus) 01/2022 - 12/2002
3	Ischemia 11/2019 - 09/2009
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2013
3	Parkinson Disease (Parkinson's Disease) 11/2007 - 01/2005
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2002
2	Hemolysis 01/2020 - 01/2017
2	Neoplasms (Cancer) 01/2016 - 01/2008
2	Neurologic Manifestations (Neurological Manifestations) 09/2015 - 02/2004
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2014 - 08/2014
2	Hyperglycemia 09/2009 - 04/2007
1	Cognitive Dysfunction 02/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2021

Drug/Important Bio-Agent (IBA)

50	IronIBA 10/2022 - 02/2002
36	Thrombin FDA Link 08/2021 - 01/2002
24	Deferoxamine (Desferal)FDA LinkGeneric 03/2022 - 02/2002
22	Hemoglobins (Hemoglobin)IBA 10/2022 - 02/2002
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
10	Lipocalin-2IBA 01/2022 - 04/2013
9	Minocycline (Cyclops)FDA LinkGeneric 05/2022 - 03/2009
7	Ferritins (Ferritin)IBA 01/2021 - 12/2003
7	Peptide Hydrolases (Proteases)FDA Link 12/2016 - 10/2006
6	Clodronic Acid (Clodronate)IBA 05/2022 - 02/2016
6	Liposomes (Liposome)IBA 05/2022 - 02/2016
6	Heme Oxygenase-1IBA 10/2021 - 12/2003
6	PeroxiredoxinsIBA 01/2021 - 01/2020
6	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2005
5	Chelating AgentsIBA 01/2019 - 02/2002
5	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2009 - 01/2002
4	Estrogens (Estrogen)FDA Link 01/2022 - 07/2005
4	Complement System Proteins (Complement)IBA 01/2021 - 07/2005
4	Thrombin Receptors (Thrombin Receptor)IBA 01/2016 - 04/2002
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021 - 01/2016
3	Oxygen (Dioxygen)IBA 02/2018 - 04/2007
3	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 04/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 03/2006
3	Messenger RNA (mRNA)IBA 01/2013 - 01/2002
3	Mitogen-Activated Protein KinasesIBA 01/2013 - 09/2009
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 11/2004
3	argatroban (MPQA)FDA Link 01/2008 - 12/2002
3	Oxidopamine (6 Hydroxydopamine)IBA 11/2007 - 01/2005
3	Transferrin (beta 2 Transferrin)IBA 02/2005 - 12/2003
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2011
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2011
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2006
2	AlbuminsIBA 01/2021 - 01/2013
2	Hemin (Panhematin)FDA Link 01/2019 - 01/2011
2	CytokinesIBA 12/2016 - 03/2009
2	Estrogen ReceptorsIBA 01/2016 - 07/2005
2	EnzymesIBA 01/2016 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 09/2009
2	Heme (Haem)IBA 01/2016 - 12/2006
2	Fulvestrant (Faslodex)FDA Link 01/2016 - 07/2005
2	Tamoxifen FDA LinkGeneric 01/2016 - 01/2011
2	ImmunosorbentsIBA 01/2016 - 01/2016
2	Collagenases (Collagenase)FDA Link 06/2011 - 12/2002
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2011 - 01/2009
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2009 - 05/2007
2	Complement C5 (Complement 5)IBA 12/2006 - 05/2004
2	HirudinsIBA 02/2004 - 01/2002
2	Transferrin Receptors (Transferrin Receptor)IBA 12/2003 - 12/2003
1	NeurotoxinsIBA 10/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Laminin (Merosin)IBA 01/2022
1	Myelin Basic ProteinIBA 10/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Proteinase-Activated ReceptorsIBA 01/2021
1	conoidin AIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2019
1	Ceruloplasmin (Ferroxidase)IBA 01/2019
1	N-acetylheparinIBA 01/2019
1	Aurintricarboxylic AcidIBA 01/2019
1	HemopexinIBA 01/2019
1	Complement Inactivating AgentsIBA 01/2019
1	Tight Junction ProteinsIBA 01/2018

Therapy/Procedure

13	Therapeutics 11/2019 - 12/2002
7	Intraventricular Injections 01/2021 - 03/2014
2	Injections 08/2021 - 01/2021
1	Endoscopes 01/2018